Market Overview

Cramer Doesn't Want To Sell Sarepta Or Twitter At Current Prices

Share:
Cramer Doesn't Want To Sell Sarepta Or Twitter At Current Prices
Related SRPT
Payor Re-Evaluation On Exondys Positive For Sarepta
Adam Feuerstein Weighs In On Novo-GBT Rumors, Undue Sarepta Volatility, Unprofitable Business Of Curing Disease
Related TWTR
Twitter Slightly Higher Off Prospects For A Premium Twitter
The Market In 5 Minutes
Twitter's User Problem Is More Serious Than You Think (Seeking Alpha)

On CNBC's Mad Money, Jim Cramer said he was surprised by a sharp decline in Sarepta Therapeutics Inc (NASDAQ: SRPT) on Thursday, but he wouldn't sell the stock at its current price level.

Cramer thinks that someone is going to figure out how to make Twitter Inc (NYSE: TWTR) profitable. He doesn't want to sell the stock at $15.

Posted-In: Mad MoneyCNBC Jim Cramer Media Best of Benzinga

 

Related Articles (SRPT + TWTR)

View Comments and Join the Discussion!